Immatics (IMTX) Share-based Compensation (2019 - 2025)
Immatics (IMTX) reported Share-based Compensation of $3.8 million for Q4 2025, down 20.57% on a YoY basis from $4.8 million in Q4 2024, and up 1.48% sequentially from $3.8 million in Q3 2025.
Immatics (IMTX) Share-based Compensation (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Share-based Compensation data on file, last reported at $3.8 million in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation fell 20.57% year-over-year to $3.8 million; the trailing twelve-month figure through Dec 2025 stood at $16.9 million (down 11.63% YoY), and the FY2025 full-year result was $17.0 million, down 11.16% from the prior year.
- Share-based Compensation rose to $3.8 million in Q4 2025, from $3.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $10.0 million in Q1 2021 to a low of -$17.5 million in Q4 2023.
- A 5-year average of $4.6 million and a median of $5.3 million in 2021 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 108769.42% in 2021 and slumped 393.7% in 2023, its largest moves.
- Tracing IMTX's Share-based Compensation over 5 years: stood at $5.4 million in 2021, then increased by 10.16% to $6.0 million in 2022, then tumbled by 393.7% to -$17.5 million in 2023, then soared by 127.64% to $4.8 million in 2024, then dropped by 20.57% to $3.8 million in 2025.
- Business Quant data shows IMTX's Share-based Compensation at $3.8 million in Q4 2025, $3.8 million in Q3 2025, and $4.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | 3.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.84 Mn |
| Dec 31, 2025 | 3.84 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Jun 30, 2025 | 4.69 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Mar 31, 2025 | 4.55 Mn |
| Dec 31, 2024 | 4.84 Mn |
| Dec 31, 2024 | 4.84 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 4.64 Mn |
| Jun 30, 2024 | 4.64 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Dec 31, 2023 | -17.51 Mn |
| Dec 31, 2023 | -17.51 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Sep 30, 2023 | 5.10 Mn |